Researchers from Hong Kong imputed transcriptomes from GWAS data and compared them to drug-induced gene expression profiles.
NBC News reports that pharmacogenomics can help match people with depression to drugs that may work best for them.
The study will combine cognitive assessments with genetic data and survey responses to gain insights into the causes of these two mental health conditions.
Researchers in Australia hope the genetic study will help take the guesswork out of prescribing medications for depression, the Hack says.
The international team of researchers also examined the genetic ties between personality traits and psychiatric disorders.
23andMe's database has enabled it to link loci to disease and fuel better understanding of diseases like depression, KQED Science says.
The company has recently launched its first diagnostic test on the market and is developing a second, which is currently in clinical trials.
In Nature this week: loci linked to major depressive disorder, and more.
With genotypes for hundreds of thousands of individuals, investigators uncovered 15 loci linked to major depressive disorder in individuals with European ancestry.
The firm plans to launch testing in the US this fall through Atlanta-based Alpha Genomix, and is looking for similar partners in Asia for a new Asia-specific panel.
Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.
US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.
A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.
In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.